Toxicity of Necrostatin-1 in Parkinson’s Disease Models

Parkinson’s disease (PD) is a neurodegenerative disorder that is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. This neuronal loss, inherent to age, is related to exposure to environmental toxins and/or a genetic predisposition. PD-induced cell death has bee...

Full description

Bibliographic Details
Main Authors: Eva Alegre-Cortés, Alicia Muriel-González, Saray Canales-Cortés, Elisabet Uribe-Carretero, Guadalupe Martínez-Chacón, Ana Aiastui, Adolfo López de Munain, Mireia Niso-Santano, Rosa A. Gonzalez-Polo, José M. Fuentes, Sokhna M. S. Yakhine-Diop
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/9/6/524
_version_ 1827715054220345344
author Eva Alegre-Cortés
Alicia Muriel-González
Saray Canales-Cortés
Elisabet Uribe-Carretero
Guadalupe Martínez-Chacón
Ana Aiastui
Adolfo López de Munain
Mireia Niso-Santano
Rosa A. Gonzalez-Polo
José M. Fuentes
Sokhna M. S. Yakhine-Diop
author_facet Eva Alegre-Cortés
Alicia Muriel-González
Saray Canales-Cortés
Elisabet Uribe-Carretero
Guadalupe Martínez-Chacón
Ana Aiastui
Adolfo López de Munain
Mireia Niso-Santano
Rosa A. Gonzalez-Polo
José M. Fuentes
Sokhna M. S. Yakhine-Diop
author_sort Eva Alegre-Cortés
collection DOAJ
description Parkinson’s disease (PD) is a neurodegenerative disorder that is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. This neuronal loss, inherent to age, is related to exposure to environmental toxins and/or a genetic predisposition. PD-induced cell death has been studied thoroughly, but its characterization remains elusive. To date, several types of cell death, including apoptosis, autophagy-induced cell death, and necrosis, have been implicated in PD progression. In this study, we evaluated necroptosis, which is a programmed type of necrosis, in primary fibroblasts from PD patients with and without the G2019S <i>leucine-rich repeat kinase 2</i> (<i>LRRK2)</i> mutation and in rotenone-treated cells (SH-SY5Y and fibroblasts). The results showed that programmed necrosis was not activated in the cells of PD patients, but it was activated in cells exposed to rotenone. Necrostatin-1 (Nec-1), an inhibitor of the necroptosis pathway, prevented rotenone-induced necroptosis in PD models. However, Nec-1 affected mitochondrial morphology and failed to protect mitochondria against rotenone toxicity. Therefore, despite the inhibition of rotenone-mediated necroptosis, PD models were susceptible to the effects of both Nec-1 and rotenone.
first_indexed 2024-03-10T19:10:11Z
format Article
id doaj.art-6e53fef3a6924a62ab14c3353d974cab
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T19:10:11Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-6e53fef3a6924a62ab14c3353d974cab2023-11-20T03:54:13ZengMDPI AGAntioxidants2076-39212020-06-019652410.3390/antiox9060524Toxicity of Necrostatin-1 in Parkinson’s Disease ModelsEva Alegre-Cortés0Alicia Muriel-González1Saray Canales-Cortés2Elisabet Uribe-Carretero3Guadalupe Martínez-Chacón4Ana Aiastui5Adolfo López de Munain6Mireia Niso-Santano7Rosa A. Gonzalez-Polo8José M. Fuentes9Sokhna M. S. Yakhine-Diop10Department Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura Avda de la Universidad s/n, 10003 Cáceres, SpainDepartment Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura Avda de la Universidad s/n, 10003 Cáceres, SpainDepartment Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura Avda de la Universidad s/n, 10003 Cáceres, SpainDepartment Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura Avda de la Universidad s/n, 10003 Cáceres, SpainDepartment Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura Avda de la Universidad s/n, 10003 Cáceres, SpainCell Culture Plataform, Donostia University Hospital, 20014 San Sebastián, SpainNeuroscience Area of Biodonostia Health Research Institute, Donostia University Hospital, 20014 San Sebastián, SpainDepartment Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura Avda de la Universidad s/n, 10003 Cáceres, SpainDepartment Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura Avda de la Universidad s/n, 10003 Cáceres, SpainDepartment Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura Avda de la Universidad s/n, 10003 Cáceres, SpainDepartment Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura Avda de la Universidad s/n, 10003 Cáceres, SpainParkinson’s disease (PD) is a neurodegenerative disorder that is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. This neuronal loss, inherent to age, is related to exposure to environmental toxins and/or a genetic predisposition. PD-induced cell death has been studied thoroughly, but its characterization remains elusive. To date, several types of cell death, including apoptosis, autophagy-induced cell death, and necrosis, have been implicated in PD progression. In this study, we evaluated necroptosis, which is a programmed type of necrosis, in primary fibroblasts from PD patients with and without the G2019S <i>leucine-rich repeat kinase 2</i> (<i>LRRK2)</i> mutation and in rotenone-treated cells (SH-SY5Y and fibroblasts). The results showed that programmed necrosis was not activated in the cells of PD patients, but it was activated in cells exposed to rotenone. Necrostatin-1 (Nec-1), an inhibitor of the necroptosis pathway, prevented rotenone-induced necroptosis in PD models. However, Nec-1 affected mitochondrial morphology and failed to protect mitochondria against rotenone toxicity. Therefore, despite the inhibition of rotenone-mediated necroptosis, PD models were susceptible to the effects of both Nec-1 and rotenone.https://www.mdpi.com/2076-3921/9/6/524mitochondriamitophagyMLKLnecroptosisRIProtenone
spellingShingle Eva Alegre-Cortés
Alicia Muriel-González
Saray Canales-Cortés
Elisabet Uribe-Carretero
Guadalupe Martínez-Chacón
Ana Aiastui
Adolfo López de Munain
Mireia Niso-Santano
Rosa A. Gonzalez-Polo
José M. Fuentes
Sokhna M. S. Yakhine-Diop
Toxicity of Necrostatin-1 in Parkinson’s Disease Models
Antioxidants
mitochondria
mitophagy
MLKL
necroptosis
RIP
rotenone
title Toxicity of Necrostatin-1 in Parkinson’s Disease Models
title_full Toxicity of Necrostatin-1 in Parkinson’s Disease Models
title_fullStr Toxicity of Necrostatin-1 in Parkinson’s Disease Models
title_full_unstemmed Toxicity of Necrostatin-1 in Parkinson’s Disease Models
title_short Toxicity of Necrostatin-1 in Parkinson’s Disease Models
title_sort toxicity of necrostatin 1 in parkinson s disease models
topic mitochondria
mitophagy
MLKL
necroptosis
RIP
rotenone
url https://www.mdpi.com/2076-3921/9/6/524
work_keys_str_mv AT evaalegrecortes toxicityofnecrostatin1inparkinsonsdiseasemodels
AT aliciamurielgonzalez toxicityofnecrostatin1inparkinsonsdiseasemodels
AT saraycanalescortes toxicityofnecrostatin1inparkinsonsdiseasemodels
AT elisabeturibecarretero toxicityofnecrostatin1inparkinsonsdiseasemodels
AT guadalupemartinezchacon toxicityofnecrostatin1inparkinsonsdiseasemodels
AT anaaiastui toxicityofnecrostatin1inparkinsonsdiseasemodels
AT adolfolopezdemunain toxicityofnecrostatin1inparkinsonsdiseasemodels
AT mireianisosantano toxicityofnecrostatin1inparkinsonsdiseasemodels
AT rosaagonzalezpolo toxicityofnecrostatin1inparkinsonsdiseasemodels
AT josemfuentes toxicityofnecrostatin1inparkinsonsdiseasemodels
AT sokhnamsyakhinediop toxicityofnecrostatin1inparkinsonsdiseasemodels